Transcatheter Aortic Valve Replacement in Patients With Severe Aortic Stenosis Who Cannot Undergo Surgery

A Technology Assessment

Jeffrey A. Tice, MD



In This Article


It is recommended that use of the SAPIEN transcatheter aortic valve meets CTAF TA Criterion 1 through 5 for safety, effectiveness and improvement in net health outcomes when used for the treatment of severe, symptomatic aortic stenosis in patients determined to be inoperable by a cardiac surgeon who can be treated using the transfemoral approach.

February 8, 2011

This is the first review of this technology by the California Technology Assessment Forum.


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.